The online home for the primary care professionals managing patients with cardiovascular disease, diabetes and related diseases.

Evidence in Practice

Saturday, 09 September 2017
A new study shows that long-term daily aspirin use in people aged ≥75 years, is linked to a higher than expected risk of disabling or fatal bleeding. While short-term aspirin use after a stroke or heart attack has clear benefits, the study authors say that older patients who take aspirin on a daily basis should also be prescribed a proton-pump inhibitor (PPI) to reduce the risk of bleeding.
Monday, 17 July 2017
A new study has announced the new QRISK3 cardiovascular disease risk prediction algorithm. The calculator is used to work out the risk of developing a heart attack or stroke over the next 10 years. The risk calculator is designed for use in the UK.
Monday, 17 July 2017
A new study led by the University of Leicester suggests that one in three people who suffer from high blood pressure are failing to take medication as prescribed by their healthcare professionals. Non-adherence to antihypertensive treatment is a critical contributor to suboptimal blood pressure control.
Monday, 17 July 2017
Two studies highlight the long-term implications of childhood obesity. The first study shows that obese children have increased arterial damage and an enhanced likelihood of pre-diabetes in adulthood which, in turn, increases the chance of developing cardiovascular disease.
Wednesday, 07 June 2017
Offering a year-long programme of weight loss classes could prevent an additional 1786 cases of cardiovascular disease for every 100,000 people compared to the existing 12-week NHS programme, according to a new study published in the Lancet.
Topics covered:
Wednesday, 07 June 2017
Men and women suffering from heart failure have a higher risk of death than people with some common types of cancer, according to results from the primary care database study. Heart failure is also accompanied by much higher rates of co-morbidity.
Tuesday, 30 May 2017
Muscle-related symptoms are less commonly reported when patients and their doctors are unaware that statin therapy is being used, compared to when they are aware, according to a new study on ASCOT-LLA trial data.
Friday, 19 May 2017
Treatment for erectile dysfunction (ED) with phosphodiesterase-5 (PDE5) inhibitors is associated with a markedly reduced risk of death, and hospitalisation for heart failure. A team from the Karolinksa Institute in Stockholm conducted a nationwide cohort study which included over 43,000 men with a first MI in Sweden.

Article search and filter